Clinical Cancer Research  Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, E. C.
Right arrow Articles by Kwong, Y. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, E. C.
Right arrow Articles by Kwong, Y. L.
Clinical Cancer Research Vol. 8, 3741-3746, December 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Aberrant Promoter Methylation in Chinese Patients with Non-Small Cell Lung Cancer: Patterns in Primary Tumors and Potential Diagnostic Application in Bronchoalevolar Lavage1

Eunice C. Chan, Shui Y. Lam, Kenneth W. Tsang, Bing Lam, James C. M. Ho, Kin H. Fu, Wah K. Lam and Yok L. Kwong2

University Department of Medicine, Queen Mary Hospital [E. C. C., K. W. T., B. L., J. C. M. H., W. K. L., Y. L. K.]; Department of Pathology, Kowloon Hospital [S. Y. L.]; and Department of Pathology, Tseung Kwan O Hospital [K. H. F.], Hong Kong

This study was aimed at defining patterns of aberrant gene methylation in non-small cell lung cancer (NSCLC) in Chinese patients and its use in detecting cancer cells in bronchoalveolar lavage (BAL).

The methylation-specific PCR (MSP) was used to study methylation of the p16, retinoic acid receptor-ß (RARß), death-associated protein (DAP) kinase, and O6-methylguanine-DNA-methyltransferase (MGMT) genes in 75 NSCLCs [44 adenocarcinomas and 31 squamous cell carcinomas (SCCs)] and 68 BALs from suspected lung cancers.

More females had adenocarcinoma than SCC (11 of 44 versus 2 of 31, P = 0.04). Aberrant methylation in at least one gene was found in 63 of 75 (84%) NSCLCs. p16, RARß, DAP kinase, and MGMT methylation was similar in adenocarcinoma and SCC. However, females with NSCLC showed more frequent p16 methylation than males (12 of 13 versus 36 of 62, P = 0.02), because of more frequent p16 methylation in female adenocarcinomas (10 of 11 versus 17 of 33, P = 0.02). This sexual difference was not observed in RARß, DAP kinase, and MGMT. At 92%, the frequency of p16 methylation in Chinese female NSCLC is one of the highest known. For BAL, MSP and cytological analysis showed concordant and discordant results in 25 of 68 and 43 of 68 samples. Of 41 MSP+/cytology- cases, 35 were eventually shown to have malignant lung lesions, 4 were at high risk but had no evidence of lung cancer, and 2 were lost to follow-up. There were two MSP-/cytology+ cases.

Frequent gene methylations were seen in Chinese NSCLC patients. More frequent p16 methylation was seen in female patients. MSP is a useful molecular adjunct for cancer cell detection in BAL samples.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
C S Chim, W W L Chan, and Y L Kwong
Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias
J. Clin. Pathol., July 1, 2008; 61(7): 844 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C.-S. Chim, R. Liang, T.-K. Fung, C.-L. Choi, and Y.-L. Kwong
Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma
J. Clin. Pathol., June 1, 2007; 60(6): 664 - 669.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Schmiemann, A. Bocking, M. Kazimirek, A. S. C. Onofre, H. E. Gabbert, R. Kappes, C. D. Gerharz, and H. J. Grote
Methylation Assay for the Diagnosis of Lung Cancer on Bronchial Aspirates: A Cohort Study
Clin. Cancer Res., November 1, 2005; 11(21): 7728 - 7734.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
O. Topaloglu, M. O. Hoque, Y. Tokumaru, J. Lee, E. Ratovitski, D. Sidransky, and C.-s. Moon
Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer
Clin. Cancer Res., April 1, 2004; 10(7): 2284 - 2288.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. N. Reddy, W. W. Jiang, M. Kim, N. Benoit, R. Taylor, J. Clinger, D. Sidransky, and J. A. Califano
Death-Associated Protein Kinase Promoter Hypermethylation in Normal Human Lymphocytes
Cancer Res., November 15, 2003; 63(22): 7694 - 7698.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.